Basic Information
ID: ALA3624841
Type: Functional
Description: Antitumor activity against bicalutamide-resistant human CWR22 cells in Balb/c athymic (nu/nu) mouse CWR22-BMSLD1 prostate cancer xenograft model assessed as tumor growth inhibition at 90 mg/kg, po qd administered for 45 days measured from day 10 to 45 during compound dosing
Organism: Homo sapiens
Cell type: CWR22
Activity Charts
Bioactivity
Activity Types for Assay ALA3624841
TGI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 471.46 | 1.94 | 1.94 |